Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Michal Staník"'
Publikováno v:
Case Reports in Oncology, Vol 17, Iss 1, Pp 537-542 (2024)
Introduction: Prostate cancer is one of the most common cancers in men. Despite the sharp rise in incidence, mortality is decreasing. ARTA preparations are preferred options for asymptomatic or mildly symptomatic patients with mCRPC. The use of enzal
Externí odkaz:
https://doaj.org/article/860706c596654c838ad4939e72dde932
Autor:
Alexandr Poprach, Denisa Malúšková, Radek Lakomý, Daniel Macík, Jiří Jarkovský, Jan Doležel, Michal Staník, Michaela Zapletalová, Ivo Čapák
Publikováno v:
Clinical Genitourinary Cancer. 17:e759-e767
Patients with clinically node-positive bladder cancer were historically considered to have uniformly poor prognosis and were frequently treated with palliative chemotherapy (CHT) only. Although retrospective data show that long-term survival with com
Autor:
Katerina Kopeckova, Milada Zemanova, Miloš Holánek, Tomas Buchler, Renata Chloupková, Igor Penka, Julia Bohosova, Radek Lakomy, Igor Kiss, Ondrej Fiala, Michal Staník, Alexandr Poprach, Bohuslav Melichar
Publikováno v:
Cancers, Vol 12, Iss 2911, p 2911 (2020)
Cancers
Volume 12
Issue 10
Cancers
Volume 12
Issue 10
The role of cytoreductive nephrectomy (CN) in treatment of locally advanced or metastatic renal cell carcinoma (mRCC) in the era of targeted therapies (TT) is still not clearly defined. The study population consisted of 730 patients with synchronous
Autor:
Michal Staník, Alexander Poprach, Simona Littnerová, Ivo Čapák, Markéta Hulová, Natália Šebová, Radek Lakomý, Jiří Jarkovský, Jan Doležel
Publikováno v:
Urologic Oncology: Seminars and Original Investigations. 40:111.e27-111.e34
Isolated retroperitoneal recurrence (IRR) in renal cancer patients after radical nephrectomy (RN) is a rare event and poses a therapeutic dilemma. We evaluated oncologic outcomes in surgically treated patients with IRR and established prognostic fact
Autor:
Marek Svoboda, Barbora Peltanová, Lenka Radová, Dalibor Pacík, Jan Dolezel, Ondrej Slaby, Petra Vesela, Michal Staník, Jaroslav Juracek, Michal Fedorko
Publikováno v:
Journal of Cellular and Molecular Medicine
Urinary microRNAs (miRNAs) are emerging as clinically useful tool for early and non‐invasive detection of various types of cancer including bladder cancer (BCA). In this study, 205 patients with BCA and 99 healthy controls were prospectively enroll
Autor:
Robert Iliev, Dalibor Pacík, Ondrej Slaby, Michal Staník, Hana Mlčochová, Tana Machackova, Marek Svoboda, Jan Dolezel, Michal Fedorko
Publikováno v:
Anticancer Research. 36:6419-6424
Background: Renal cell carcinoma (RCC) is the most common neoplasm of adult kidney accounting for about 3% of adult malignancies. P-Element induced wimpy testis (PIWI)-interacting RNAs (piRNAs) are a new class of naturally occurring, short non-coding
Autor:
Michal Staník, Jiri Sana, Dalibor Pacík, Michal Fedorko, Karolina Trachtova, Júlia Bohošová, Alexandr Poprach, Jan Dolezel, Ondrej Slaby, Marek Svoboda, Adela Kubickova
Publikováno v:
Cancer Research. 80:3124-3124
Introduction: Renal cell carcinoma (RCC) is due to its asymptomatic nature usually diagnosed too late or incidentally during the examination for other indications. There is currently none sufficiently sensitive and reliable biomarker for diagnosis, p
Autor:
Michal Staník, Marek Svoboda, Lenka Radová, Jaroslav Juracek, Ondrej Slaby, Petra Vesela, Jan Dolezel
Publikováno v:
Urologic oncology. 37(3)
Non-muscle-invasive bladder cancer (NMIBC) is a heterogeneous disease characterized by a high primary tumor recurrence rate. Current prognostic systems used for predicting recurrence in individual patients have limitations and do not consider the bio
Publikováno v:
International urology and nephrology. 50(8)
Superparamagnetic nanoparticles of iron oxide (SPION) were shown to be non-inferior to standard radioisotope tracer in breast cancer and may be used as an alternative to identify sentinel lymph nodes (SLN). The aim of this study was to assess the fea
Autor:
Jaroslav Juracek, Dalibor Pacík, Michal Fedorko, Jan Dolezel, Tomas Buchler, Marek Svoboda, Michal Staník, Ondrej Slaby, Alexandr Poprach
Publikováno v:
Biochemia Medica
Volume 27
Issue 2
Volume 27
Issue 2
Introduction: Urinary microRNAs (miRNAs) are emerging as a clinically useful tool for early and non-invasive detection of various types of cancer. The aim of this study was to evaluate whether let-7 family miRNAs differ in their urinary concentration